
    
      In total, 20 BDD patients aged 16 through 65 will participate. To be eligible they must meet
      DSM-IV criteria for BDD, have a score of 20 or greater on the BDD modification of the Yale
      Brown Obsessive-Compulsive Scale (BDD-YBOCS) and be on a stable, therapeutic does of an SRI
      (at least 12 weeks on the SRI with 8 weeks at a therapeutic dose: acceptable medications
      (therapeutic daily doses) are citalopram (40mg), clomipramine (150mg), fluoxetine (40mg),
      fluvoxamine (150mg), paroxetine (40mg), sertraline (50mg), and venlafaxine (150mg).
    
  